Drug Repositioning through Systematic Mining of Gene Coexpression Networks in Cancer.

Area of Science:

• Genomics
• Bioinformatics
• Cancer Biology

Background:

• Gene coexpression network analysis is crucial for understanding cancer development.
• Existing cancer gene expression studies lack normalized, integrated meta-analysis frameworks.

Purpose of the Study:

• To create a normalized, integrated resource of gene coexpression modules across multiple human cancers.
• To identify functionally prominent hub genes associated with specific tumor features.
• To explore potential therapeutic applications using network analysis.

Main Methods:

• Utilized weighted gene coexpression network (WGCNA) methodology on 82 microarray datasets from 9 major human cancer types.
• Identified over 3,000 gene coexpression modules.
• Ranked genes by connectivity within modules to identify hub genes.

Main Results:

• Discovered >3,000 robust gene coexpression modules associated with tumor features like proliferation, hypoxia, and angiogenesis.
• Identified module-specific functionally prominent hub genes.
• Positioned known cancer drug targets and predicted Anakinra as a potential therapeutic for colorectal cancer.

Conclusions:

• The generated collection of gene coexpression modules provides a valuable, normalized resource for cancer research.
• This network-based approach facilitates the identification of novel cancer mechanisms and therapeutic targets.
• Highlights the potential of repurposing existing drugs, such as Anakinra, for cancer treatment.